| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |